FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended to predict the development of bowel necrosis in patients with acute mesenteric ischemia. In venous blood, the content of total and cytotoxic lymphocytes in patients is determined; integral indicators of total lymphocytes (P1) and cytotoxic lymphocytes (P2) are calculated in relation to their content in the patient to the average value in healthy individuals, the prognostic index (K) against the ratio of the integral indicator (P1) to the integral indicator (P2) is calculated and for values of the coefficient less than 0.5, the development of intestinal necrosis is predicted.
EFFECT: method provides an increase in the accuracy of the prognosis of the development of intestinal necrosis in patients with acute mesenteric ischemia.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR INTESTINAL NECROSIS ACCOMPANYING MESENTERIC ISCHEMIA EXPERIMENTALLY | 2014 |
|
RU2552338C1 |
| CYTOMETRIC METHOD FOR PREDICTION OF CLINICAL OUTCOME OF WIDESPREAD PURULENT PERITONITIS | 2018 |
|
RU2691742C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS OF MESENCHYMAL STROMAL CELLS FOR INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2463596C1 |
| METHOD FOR DETERMINING VIABILITY OF SMALL INTESTINE | 2018 |
|
RU2705940C1 |
| METHOD OF PREDICTING INFECTIOUS COMPLICATIONS OF ATOPIC DERMATITIS | 2008 |
|
RU2350960C1 |
| METHOD FOR INDIVIDUAL MATCHING IMMUNOCORRECTORS FOR TREATING PATIENTS WITH PERITONITIS | 2002 |
|
RU2243563C2 |
| METHOD FOR DIAGNOSING INTESTINAL VIABILITY AT MESENTERIC THROMBOSIS | 2002 |
|
RU2208380C1 |
| METHOD FOR DIAGNOSING AN ACUTE DISORDER OF THE MESENTERIC CIRCULATION | 2020 |
|
RU2756869C1 |
| METHOD OF TREATING PATIENTS WITH TOTAL NECROSIS OF SMALL INTESTINE | 2010 |
|
RU2448659C2 |
| METHOD OF INTESTINE INFARCTION DIAGNOSIS | 1995 |
|
RU2117945C1 |
